You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herpes Simplex Virus

Showing 1 - 25 of 8,461
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)

Recruiting
  • Virus
  • +3 more
  • Purell Hand Sanitizer
  • Medical Grade Mineral Oil
  • Pocatello, Idaho
  • +2 more
Nov 13, 2023

Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Completed
  • Neonatal Herpes Simplex Infection
  • +7 more
    • Copenhagen, Denmark
    • +1 more
    Dec 25, 2022

    HSV Trial (Pritelivir)

    Available
    • HSV
    • (no location specified)
    Apr 25, 2023

    NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

    Suspended
    • HSV-2 Infection
    • Herpes Simplex Virus Infection
    • Diagnostic Test: NOWDx HSV-2 Test
    • Tempe, Arizona
    • +2 more
    Sep 29, 2022

    Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)

    Recruiting
    • Neonatal Herpes Simplex Infection
    • Birmingham, Alabama
      University of Alabama - Children's of Alabama
    Sep 12, 2022

    Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia Trial (Acyclovir)

    Not yet recruiting
    • Pneumonia, Viral
    • +4 more
    • (no location specified)
    Nov 16, 2023

    Herpes Simplex-virus Type 1 (HSV-1) Reactivation

    Recruiting
    • Tracheobronchitis
    • Herpes Simplex Infection
    • Patients with herpes-simplex infection requiring bronchoscopy
    • Münster, Germany
      University Hospital Münster
    Apr 11, 2022

    Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?

    Recruiting
    • Cervical Cancer
    • +2 more
    • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
    • Shanghai, Shanghai, China
      Shanghai Tenth People's Hospital
    Mar 31, 2023

    Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

    Recruiting
    • Sarcoma
    • +8 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, Jiangsu, China
      Xuzhou Second People's Hospital
    May 8, 2023

    Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

    Recruiting
    • Sarcoma
    • +9 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Linyi, Shandong, China
      Linyi Central Hospital
    Jul 25, 2023

    Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

    Recruiting
    • Osteosarcoma
    • +3 more
    • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
    • Xi'an, Shaanxi, China
      Xi'an Honghui Hospital
    May 8, 2023

    Herpes Labialis Trial in Germany (drug, behavioral, procedure)

    Active, not recruiting
    • Herpes Labialis
    • HDIT101 (blinded therapy)
    • +5 more
    • Berlin, Germany
    • +4 more
    Jan 26, 2023

    Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, Shanghai, China
      Shanghai Tenth People's Hospital
    Mar 26, 2023

    Herpes Simplex Oral Trial in Murray (EDTA, Abreva)

    Enrolling by invitation
    • Herpes Simplex Oral
    • Murray, Utah
      University of Utah MidValley Dermatology
    Jan 25, 2022

    Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

    Recruiting
    • Head and Neck Cancer
    • +6 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, China
      Eye & ENT Hospital of Fudan University
    Apr 13, 2023

    Melanoma Trial in Beijing (OH2 injection, HX008 injection)

    Recruiting
    • Melanoma
    • OH2 injection
    • HX008 injection
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Jan 28, 2023

    Frequency of Symptomatic Herpes Virus I and II in HIV Infected

    Recruiting
    • HIV Disease
    • +2 more
    • Blood draw
    • Los Angeles, California
      Global Research Institute
    Apr 9, 2023

    Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg

    Withdrawn
    • Herpes Simplex Virus Keratitis
    • oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
    • oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
    • New York, New York
      New York University School of Medicine
    Dec 29, 2021

    Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

    Recruiting
    • Lung Cancer
    • +11 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Anqing, Anhui, China
      The PLA Navy Anqing Hospital
    May 23, 2023

    Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

    Not yet recruiting
    • Genital Herpes Simplex Type 2
    • BNT163
    • Placebo
    • (no location specified)
    Jun 21, 2022

    Uterine Cervical Tumors Trial in Wuhan (BS-006)

    Not yet recruiting
    • Uterine Cervical Neoplasms
    • BS-006
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jun 6, 2022

    HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)

    Completed
    Has Results
    • HSV
    • Herpes Labialis
    • Squaric Acid Dibutyl Ester
    • Saint Paul, Minnesota
      Prism Clinical Research, LLC
    Oct 5, 2021

    Viral Keratitis, Blindness Eye, Herpes Simplex Virus Infection Trial in Shanghai (BD111 Adult single group Dose)

    Completed
    • Viral Keratitis
    • +3 more
    • BD111 Adult single group Dose
    • Shanghai, Shanghai, China
      Eye & Ent Hospital of Fudan University
    Aug 20, 2022

    Recurrent Genital Herpes Trial (UB-621)

    Not yet recruiting
    • Recurrent Genital Herpes
    • UB-621
    • (no location specified)
    May 16, 2022

    Genital Herpes Trial in Seattle (acyclovir, valacyclovir)

    Completed
    Has Results
    • Genital Herpes
    • Seattle, Washington
      University of Washington Virology Research Clinic
    Nov 16, 2021